📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-18 16:25
206 analysed today
FollowTelegram
206
Today
149,607
All-time analysed
42,901
Positive
6,659
Negative
91,372
Neutral
8,607
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
3 announcements match the current filters (relevance ≥ 5).
Srestha Finvest Posts Q1 Net Loss of ₹27.43 Cr on ₹38.86 Cr NPA Provisioning
Srestha Finvest reported a consolidated net loss of ₹27.43 crore for the quarter ended June 30, 2026, dropping sharply from a net profit of ₹2.17 crore in the year-ago quarter. Total revenue from operations declined 66.7% YoY to ₹1.22 crore (₹122.31 lakhs). The heavy loss was predominantly driven by a surge in NPA provisions amounting to ₹38.86 crore (₹3,885.52 lakhs). Additionally, the board noted penalties imposed by BSE and MSEI for delayed compliance submissions.
Confidence: HIGH
What changedThe company swung to a severe net loss of ₹27.43 crore due to an aggressive ₹38.86 crore provision against NPAs.
Why it mattersExtensive provisioning wipes out operating earnings, eroding capital employed and putting balance sheet health under pressure.
Consolidated Net Loss: ₹2,743.06 lakhsProvision for NPA: ₹3,885.52 lakhsRevenue from operations: ₹122.31 lakhsBasic EPS: ₹-0.158
📅 Short termNegative sentiment is likely to persist given the large quarterly loss, asset deterioration, and exchange compliance penalties.
📈 Long termTurnaround hinges on cleaning up bad assets and reviving revenue generation across lending and investment portfolios.
⚠ Risk flags
- Substantial surge in NPA provisioning to ₹38.86 crore
- Unprovided interest of ₹17.06 lakhs on disputed borrowings pending legal advice
- Penalties imposed by exchanges for delayed LODR compliance filings
Key Highlights
Consolidated Net Loss stood at ₹27.43 crore against a net profit of ₹2.17 crore in Q1 previous year
Provision for NPA spiked sharply to ₹38.86 crore (₹3,885.52 lakhs) from Nil in Q1 FY25
Revenue from operations fell 66.7% YoY to ₹1.22 crore (₹122.31 lakhs)
Allotted 11.75 crore equity shares pursuant to warrant conversions on April 13, 2026
BSE and MSEI imposed fines for delayed submission of shareholding pattern for the quarter ended June 30, 2026
👀 What to Watch
Monitor asset quality disclosures, loan recovery progress in the lending division, and resolution of disputed interest claims.
Srestha Finvest Allots 15.26 Cr Equity Shares on Warrant Conversion; Inflow of Rs 12.02 Cr
Srestha Finvest has approved the allotment of 15,25,79,365 equity shares of face value Re. 1 at an issue price of Rs. 1.05 per share upon conversion of warrants on a preferential basis. The allotment follows receipt of balance consideration aggregating Rs. 12.02 crore from two non-promoter allottees, Sneha Bhandari and Pratibha Jain. Following this tranche, Sneha Bhandari holds 21.00 crore shares (11.02% stake). Out of the 85.30 crore warrants issued in February 2025, 58.29 crore warrants remain pending conversion.
Confidence: HIGH
What changedAllotment of 15.26 crore equity shares upon conversion of warrants, bringing in Rs. 12.02 crore of balance warrant funds.
Why it mattersProvides Rs. 12.02 crore in cash inflows (approx. 31.6% of current market cap) to strengthen liquidity, offset by substantial equity dilution.
Shares Allotted: 15,25,79,365Issue Price per Share: Rs 1.05Balance Funds Received: Rs 12,01,56,250Funds Received vs Market Cap: ~31.6%Warrants Pending Conversion: 58,29,20,635
📅 Short termTrading liquidity increases as 15.26 crore shares are listed, while the company's immediate cash reserves expand by Rs. 12.02 crore.
📈 Long termLong-term per-share value depends on productive capital deployment, given past TTM losses of Rs. 8 crore and a large pending conversion overhang of 58.29 crore warrants.
⚠ Risk flags
- Substantial equity dilution
- Potential further dilution from 58.29 crore unconverted warrants
- Persistent operational losses (TTM PAT of Rs -8 Cr)
Key Highlights
Allotted 15,25,79,365 equity shares at an issue price of Rs. 1.05 per share (including Rs. 0.05 premium).
Received balance warrant consideration of Rs. 12,01,56,250 from 2 non-promoter allottees.
Sneha Bhandari allotted 14.75 crore shares, taking post-issue holding to 21.00 crore shares (11.02%).
58,29,20,635 convertible warrants remain pending for conversion.
👀 What to Watch
Track the deployment of the Rs. 12.02 crore fresh capital in upcoming quarterly updates and monitor conversion timelines for the remaining 58.29 crore warrants.
Srestha Finvest allots 15.26 Cr shares on warrant conversion, receives Rs 12.02 Cr
Srestha Finvest has approved the allotment of 15,25,79,365 equity shares of Re 1 face value at an issue price of Rs 1.05 per share pursuant to warrant conversion. The company received Rs 12.02 crore as balance consideration (75%) from two non-promoter allottees. Following this conversion, Sneha Bhandari holds an 11.02% stake (21.00 crore shares), while 58.29 crore warrants remain pending for conversion out of the 85.30 crore warrants issued in February 2025.
Confidence: HIGH
What changed15.26 crore warrants were converted into equity shares, bringing in Rs 12.02 crore in cash and expanding the total paid-up share capital.
Why it mattersThe Rs 12.02 crore cash infusion is substantial relative to the company's Rs 38 crore market cap, though it brings significant share capital dilution.
Shares allotted: 15,25,79,365Issue price per share: Rs 1.05Balance funds received: Rs 12,01,56,250Funds received vs Market cap: ~31.6%Pending warrants: 58,29,20,635
📅 Short termThe newly allotted shares will increase the circulating floating stock, while the cash improves immediate liquid funds.
📈 Long termWhile equity infusion provides capital to scale, long-term value creation depends on reversing persistent operational losses (TTM net profit of Rs -8 Cr).
⚠ Risk flags
- Substantial equity dilution from current and remaining 58.29 crore pending warrants
- Persistent operational losses and negative operating margins
Key Highlights
Allotment of 15,25,79,365 equity shares of face value Re 1 each at Rs 1.05 per share.
Received Rs 12,01,56,250 (Rs 12.02 crore) as balance 75% warrant consideration.
Sneha Bhandari converted 14.75 crore warrants, taking her holding to 21.00 crore shares (11.02%).
58,29,20,635 convertible warrants remain pending for conversion out of 85.30 crore total warrants.
👀 What to Watch
Track the deployment of the newly raised funds into business operations and monitor subsequent dilution as the remaining 58.29 crore warrants approach conversion deadlines.
